Background: Hepatocellular carcinoma (HCC) can be treated by local and regional methods of percutaneous interventional radiological techniques. Indications depend on tumor size, type and stage, as well as patient’s condition, liver function and co-morbidities. According to international classification systems such as Barcelona Clinic Liver Cancer (BCLC) classification, very early, early or intermediate staged tumors can be treated either with ablative methods or with transarterial chemoembolization (TACE), depending on tumor characteristics. The combination of both allows for individualized forms of treatment with the ultimate goal of improving response and survival. In recent years, a lot of research has been carried out in combining locor...
Hepatocellular carcinoma (HCC) was the sixth most common cancer and the third cause of cancer-relate...
With the current practice of surveillance programs in high-risk patients, early stage hepatocellular...
Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and has an in...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and has an in...
Loco-regional interventional treatments continue to evolve and to play a major role in the therapeut...
Loco-regional interventional treatments continue to evolve and to play a major role in the therapeut...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
In recent years, a combination of intervention therapies has been widely applied in the treatment o...
During the last years, many local and regional techniques have been introduced, helping, together wi...
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its mortality is th...
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its mortality is th...
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its mortality is th...
Hepatocellular carcinoma (HCC) was the sixth most common cancer and the third cause of cancer-relate...
Hepatocellular carcinoma (HCC) was the sixth most common cancer and the third cause of cancer-relate...
With the current practice of surveillance programs in high-risk patients, early stage hepatocellular...
Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and has an in...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and has an in...
Loco-regional interventional treatments continue to evolve and to play a major role in the therapeut...
Loco-regional interventional treatments continue to evolve and to play a major role in the therapeut...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
In recent years, a combination of intervention therapies has been widely applied in the treatment o...
During the last years, many local and regional techniques have been introduced, helping, together wi...
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its mortality is th...
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its mortality is th...
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its mortality is th...
Hepatocellular carcinoma (HCC) was the sixth most common cancer and the third cause of cancer-relate...
Hepatocellular carcinoma (HCC) was the sixth most common cancer and the third cause of cancer-relate...
With the current practice of surveillance programs in high-risk patients, early stage hepatocellular...
Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has...